Selecta Biosciences to Participate in Upcoming Investor Conferences
WATERTOWN, Mass., Aug. 03, 2020 (GLOBE NEWSWIRE) — Selecta Biosciences, Inc. (NASDAQ: SELB), a clinical-stage biotechnology company focused on unlocking […]
WATERTOWN, Mass., Aug. 03, 2020 (GLOBE NEWSWIRE) — Selecta Biosciences, Inc. (NASDAQ: SELB), a clinical-stage biotechnology company focused on unlocking […]
WATERTOWN, Mass., Aug. 03, 2020 (GLOBE NEWSWIRE) — Aileron Therapeutics (NASDAQ:ALRN) today announced that Manuel Aivado, M.D., Ph.D., President and […]
HOUSTON, Aug. 03, 2020 (GLOBE NEWSWIRE) — Apache Corporation (NASDAQ: APA) today announced the commencement of tender offers (each, an […]
PARSIPPANY, N.J., Aug. 03, 2020 (GLOBE NEWSWIRE) — Avis Budget Group, Inc. (NASDAQ: CAR) (the “Company”) announced today that its […]
NEW YORK, Aug. 03, 2020 (GLOBE NEWSWIRE) — Intercept Pharmaceuticals, Inc. (Nasdaq:ICPT), a biopharmaceutical company focused on the development and […]
HOUSTON, Aug. 03, 2020 (GLOBE NEWSWIRE) — RigNet, Inc. (NASDAQ: RNET) today announced that it will release its second quarter […]
SAN DIEGO, Aug. 03, 2020 (GLOBE NEWSWIRE) — TRACON Pharmaceuticals (Nasdaq: TCON), a clinical stage biopharmaceutical company focused on the […]
CORAL GABLES, Fla., Aug. 03, 2020 (GLOBE NEWSWIRE) — Catalyst Pharmaceuticals, Inc. (Catalyst) (Nasdaq: CPRX), a commercial-stage biopharmaceutical company focused […]
HAMPTON, N.J., Aug. 03, 2020 (GLOBE NEWSWIRE) — Celldex Therapeutics, Inc. (Nasdaq:CLDX) will report second quarter 2020 financial results on […]
CAMBRIDGE, Mass., Aug. 03, 2020 (GLOBE NEWSWIRE) — Intellia Therapeutics, Inc. (NASDAQ:NTLA), a leading genome editing company focused on developing […]